These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 8622645

  • 1. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo.
    Lemon BD, Freedman LP.
    Mol Cell Biol; 1996 Mar; 16(3):1006-16. PubMed ID: 8622645
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
    Thompson PD, Hsieh JC, Whitfield GK, Haussler CA, Jurutka PW, Galligan MA, Tillman JB, Spindler SR, Haussler MR.
    J Cell Biochem; 1999 Dec 01; 75(3):462-80. PubMed ID: 10536369
    [Abstract] [Full Text] [Related]

  • 3. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK.
    Bone; 1995 Aug 01; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [Abstract] [Full Text] [Related]

  • 4. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M, Freedman LP, Li H, Christakos S.
    Mol Endocrinol; 1998 Sep 01; 12(9):1367-79. PubMed ID: 9731705
    [Abstract] [Full Text] [Related]

  • 5. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.
    Thompson PD, Remus LS, Hsieh JC, Jurutka PW, Whitfield GK, Galligan MA, Encinas Dominguez C, Haussler CA, Haussler MR.
    J Mol Endocrinol; 2001 Oct 01; 27(2):211-27. PubMed ID: 11564604
    [Abstract] [Full Text] [Related]

  • 6. Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation.
    Schräder M, Nayeri S, Kahlen JP, Müller KM, Carlberg C.
    Mol Cell Biol; 1995 Mar 01; 15(3):1154-61. PubMed ID: 7862109
    [Abstract] [Full Text] [Related]

  • 7. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
    Kephart DD, Walfish PG, DeLuca H, Butt TR.
    Mol Endocrinol; 1996 Apr 01; 10(4):408-19. PubMed ID: 8721985
    [Abstract] [Full Text] [Related]

  • 8. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation.
    Qi JS, Desai-Yajnik V, Greene ME, Raaka BM, Samuels HH.
    Mol Cell Biol; 1995 Mar 01; 15(3):1817-25. PubMed ID: 7862171
    [Abstract] [Full Text] [Related]

  • 9. The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors.
    Carlberg C, Mathiasen IS, Saurat JH, Binderup L.
    J Steroid Biochem Mol Biol; 1994 Nov 01; 51(3-4):137-42. PubMed ID: 7981122
    [Abstract] [Full Text] [Related]

  • 10. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
    Bettoun DJ, Burris TP, Houck KA, Buck DW, Stayrook KR, Khalifa B, Lu J, Chin WW, Nagpal S.
    Mol Endocrinol; 2003 Nov 01; 17(11):2320-8. PubMed ID: 12893883
    [Abstract] [Full Text] [Related]

  • 11. Modulation of nuclear receptor interactions by ligands: kinetic analysis using surface plasmon resonance.
    Cheskis B, Freedman LP.
    Biochemistry; 1996 Mar 12; 35(10):3309-18. PubMed ID: 8605168
    [Abstract] [Full Text] [Related]

  • 12. Ligand modulates the conversion of DNA-bound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers.
    Cheskis B, Freedman LP.
    Mol Cell Biol; 1994 May 12; 14(5):3329-38. PubMed ID: 8164684
    [Abstract] [Full Text] [Related]

  • 13. L7 protein is a coregulator of vitamin D receptor-retinoid X receptor-mediated transactivation.
    Berghöfer-Hochheimer Y, Zurek C, Wölfl S, Hemmerich P, Munder T.
    J Cell Biochem; 1998 Apr 01; 69(1):1-12. PubMed ID: 9513041
    [Abstract] [Full Text] [Related]

  • 14. Retinoid X receptor:vitamin D3 receptor heterodimers promote stable preinitiation complex formation and direct 1,25-dihydroxyvitamin D3-dependent cell-free transcription.
    Lemon BD, Fondell JD, Freedman LP.
    Mol Cell Biol; 1997 Apr 01; 17(4):1923-37. PubMed ID: 9121440
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells.
    Botling J, Oberg F, Törmä H, Tuohimaa P, Bläuer M, Nilsson K.
    Cell Growth Differ; 1996 Sep 01; 7(9):1239-49. PubMed ID: 8877104
    [Abstract] [Full Text] [Related]

  • 16. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo.
    Li XY, Xiao JH, Feng X, Qin L, Voorhees JJ.
    J Invest Dermatol; 1997 Apr 01; 108(4):506-12. PubMed ID: 9077482
    [Abstract] [Full Text] [Related]

  • 17. Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA.
    Kahlen JP, Carlberg C.
    Nucleic Acids Res; 1997 Nov 01; 25(21):4307-13. PubMed ID: 9336462
    [Abstract] [Full Text] [Related]

  • 18. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
    Staal A, van Wijnen AJ, Birkenhäger JC, Pols HA, Prahl J, DeLuca H, Gaub MP, Lian JB, Stein GS, van Leeuwen JP, Stein JL.
    Mol Endocrinol; 1996 Nov 01; 10(11):1444-56. PubMed ID: 8923469
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D interferes with transactivation of the growth hormone gene by thyroid hormone and retinoic acid.
    Garcia-Villalba P, Jimenez-Lara AM, Aranda A.
    Mol Cell Biol; 1996 Jan 01; 16(1):318-27. PubMed ID: 8524311
    [Abstract] [Full Text] [Related]

  • 20. Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid-X receptors.
    Fernandez-Martin JL, Kurian S, Farmer P, Nanes MS.
    Mol Cell Endocrinol; 1998 Jun 25; 141(1-2):65-72. PubMed ID: 9723887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.